X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (12) 12
index medicus (12) 12
cardiovascular (11) 11
humans (10) 10
stents (9) 9
cardiology (8) 8
care and treatment (8) 8
female (8) 8
male (8) 8
percutaneous coronary intervention (8) 8
abridged index medicus (7) 7
diabetes mellitus (7) 7
heart attacks (7) 7
stent (7) 7
treatment outcome (7) 7
acute coronary syndromes (6) 6
aged (6) 6
cardiology and cardiovascular medicine (6) 6
diabetes (6) 6
internal medicine (6) 6
middle aged (6) 6
mortality (6) 6
myocardial infarction (6) 6
thrombosis (6) 6
clopidogrel (5) 5
drug-eluting stent (5) 5
risk factors (5) 5
transluminal angioplasty (5) 5
angiography (4) 4
aspirin (4) 4
atherosclerosis (4) 4
bare-metal stents (4) 4
cardiovascular disease (4) 4
cardiovascular diseases (4) 4
coronary vessels (4) 4
coronary-artery-disease (4) 4
dual antiplatelet therapy (4) 4
heart attack (4) 4
medical imaging (4) 4
medical research (4) 4
medicine, experimental (4) 4
medicine, general & internal (4) 4
patients (4) 4
research (4) 4
st elevation myocardial infarction - therapy (4) 4
stent thrombosis (4) 4
studies (4) 4
therapy (4) 4
ticagrelor (4) 4
analysis (3) 3
artery-disease (3) 3
clinical outcomes (3) 3
clinical trials (3) 3
coronary heart disease (3) 3
design (3) 3
diabetes mellitus - physiopathology (3) 3
drug delivery (3) 3
drug-eluting stents (3) 3
heart (3) 3
impact (3) 3
implants (3) 3
intervention (3) 3
lesions (3) 3
meta-analysis (3) 3
metaanalysis (3) 3
patient outcomes (3) 3
prevention (3) 3
primary angioplasty (3) 3
prognosis (3) 3
revascularization (3) 3
risk assessment (3) 3
thromboembolism (3) 3
5-year follow-up (2) 2
acute coronary syndrome (2) 2
acute coronary syndrome - drug therapy (2) 2
adult (2) 2
aged, 80 and over (2) 2
american-college (2) 2
angiogenesis inhibitors (2) 2
antagonists (2) 2
antithrombotic therapy (2) 2
atrial-fibrillation (2) 2
cardiac and cardiovascular systems (2) 2
cardiac patients (2) 2
circulation (2) 2
clinical-outcomes (2) 2
clinical-trial (2) 2
coronary stenosis - therapy (2) 2
creatinine (2) 2
diabetics (2) 2
diuretics (2) 2
double-blind method (2) 2
drug therapy, combination (2) 2
drug-eluting stents - adverse effects (2) 2
elevation myocardial-infarction (2) 2
endocrinology & metabolism (2) 2
everolimus (2) 2
everolimus-eluting stent (2) 2
fractional flow reserve (2) 2
fractional flow reserve, myocardial - physiology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9824, pp. 1393 - 1402
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 23, pp. 2705 - 2715
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 58, Issue 1, pp. 11 - 18
Objectives The purpose of this study was to compare the safety and efficacy of the Xience V (Abbott Vascular, Santa Clara, California) everolimus-eluting stent... 
Cardiovascular | Internal Medicine | stent thrombosis | drug-eluting stent | myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | ARTERY-DISEASE | Cardiology | Stent (Surgery) | Angiogenesis inhibitors | Paclitaxel
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 118, Issue 9, pp. 1293 - 1299
Journal Article
JACC: Cardiovascular Imaging, ISSN 1936-878X, 2016, Volume 10, Issue 4, pp. 451 - 458
Abstract Objectives We sought to investigate the relationship between thin-cap fibroatheromas (TCFAs) on major adverse cardiac events (MACEs) arising from... 
Cardiovascular | major adverse cardiac event(s) | diabetes mellitus | thin-cap fibroatheroma
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 62, Issue 6, pp. 496 - 504
Objectives The authors investigated the relative safety and efficacy of different drug-eluting stents (DES) and bare metal stents (BMS) in patients with... 
Cardiovascular | Internal Medicine | meta-analysis | bare-metal stent(s) | stent thrombosis | drug-eluting stent(s) | Sects | Care and treatment | Patient outcomes | Heart attack | Stent (Surgery) | Studies | Heart attacks | Stents | Clinical outcomes
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2012, Volume 5, Issue 11, pp. 1141 - 1149
Objectives This study sought to study the second-generation everolimus-eluting stent (EES) as compared with first-generation sirolimus-eluting (SES) and... 
Cardiovascular | restenosis | SCAAR | sirolimus-eluting stent | everolimus-eluting stent | paclitaxel-eluting stent | stent thrombosis | all-cause mortality | condensed abstract | diabetes mellitus
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2011, Volume 4, Issue 10, pp. 1104 - 1115
Objectives This study sought to compare the clinical outcomes of everolimus-eluting stents (EES) versus paclitaxel-eluting stents (PES) in patients with acute... 
Cardiovascular | paclitaxel | everolimus | acute coronary syndrome | stent thrombosis | drug-eluting stent(s)
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2011, Volume 4, Issue 11, pp. 1209 - 1215
Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents: Pooled... 
Cardiovascular | everolimus-eluting stent(s) | lesion length | reference vessel diameter | paclitaxel-eluting stent(s)
Journal Article
Journal Article
AMERICAN HEART JOURNAL, ISSN 0002-8703, 06/2017, Volume 188, pp. 11 - 17
Background The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention with second-generation drug eluting stents (DESs)... 
BIVALIRUDIN | CLOPIDOGREL THERAPY | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR ANGIOGRAPHY | HEART-ASSOCIATION | PCI | AMERICAN-COLLEGE | COLLEGE-OF-CARDIOLOGY | DURATION | DISCONTINUATION | Prospective Studies | Purinergic P2Y Receptor Antagonists - administration & dosage | Follow-Up Studies | Antithrombins - administration & dosage | ST Elevation Myocardial Infarction - diagnosis | Hirudins - administration & dosage | ST Elevation Myocardial Infarction - therapy | Dose-Response Relationship, Drug | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Prasugrel Hydrochloride - administration & dosage | Drug Therapy, Combination | Drug-Eluting Stents | Survival Rate - trends | Peptide Fragments - administration & dosage | Postoperative Period | Europe - epidemiology | Treatment Outcome | Adenosine - administration & dosage | Recombinant Proteins - administration & dosage | Disease-Free Survival | ST Elevation Myocardial Infarction - mortality | Adenosine - analogs & derivatives | Cause of Death - trends | Percutaneous Coronary Intervention | Transluminal angioplasty | Clinical trials | Stent (Surgery) | Heart attack | Medical care, Cost of | Medical research | Medicine, Experimental | Design and construction | Cardiology | atrial-fibrillation | cardiovascular angiography | american-college | network metaanalysis | heart-association | Kardiologi | Cardiac and Cardiovascular Systems | percutaneous coronary intervention | clopidogrel therapy | segment elevation | Cardiovascular System & Cardiology | college-of-cardiology | non-inferiority trial
Journal Article